From Name

From Email

To Name

To Email

Message

2021 health plans granted leeway to limit consumers' benefit from drug coupons

from Kaiser Health News

2021 health plans granted leeway to limit consumers' benefit from drug coupons Kaiser Health News Without medication to manage her plaque psoriasis, Jennifer Brown’s face, scalp, trunk and neck periodically become covered in painful red, flaky patches so dry they crack and bleed. She has gotten relief from medications, but they come at a high price. For a while she was on Humira, made by AbbVie, with an average retail price of roughly $8,600 for two monthly injections. When that drug stopped working for her, Brown’s doctor switched her to a different drug. Today she is using another injectable, Skyrizi, also by AbbVie, which costs about $36,000 for two quarterly injections — nearly 40% more annually than Humira. READ MORE

more